GSK plc GSK | NYSE
$50.51
-$0.70 | -1.37%
TREND SIGNAL:
|2026-10-21
|2026-10-21
Next Earnings: Oct 28, 2026
Company Overview:
Market Cap:
$102.60B
Trailing PE:
21.4x
FWD PE *:
13.5x
Payout Ratio (TTM):
56.9%
52-Week Range:
$42.85 - $61.70
* Forward PE is based on street estimates.
10 Year GSK Performance Metrics:
Total Return (with DRIP):
94.6% (6.89% CAGR)
Total Return (no DRIP):
69.2% (5.40% CAGR)
Share Price:
24.2% (2.19% CAGR)
Yield on Cost (with DRIP):
6.94%
Total Invested:
$10,000
Total Value (with DRIP):
$19,463
Total Return $ (with DRIP):
$9,463
Dividend Increase:
-6.8% (-0.71% CAGR)
Dividend Yield (FWD):
3.56% ($1.80)
GSK 10-yr Total Return ($10K invested)
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
GSK Share Price
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
GSK Price CAGR:1Y: 10.91%2Y: 15.32%5Y: 4.90%10Y: 2.19%
GSK Dividend Charts
GSK Dividend CAGR:1Y: 4.03%2Y: 7.64%5Y: -2.77%10Y: -0.92%
GSK Dividend Payout Ratio CAGR:1Y: 417.58%2Y: 0.00%5Y: 15.47%10Y: 3.88%
GSK Dividend to FCF Ratio CAGR:1Y: -26.26%2Y: -12.53%5Y: -13.67%10Y: -6.85%
Unlock All Reports & Research Dividend Stocks like a BOSS!
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
GSK Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
GSK Revenue CAGR:1Y: -1.61%2Y: 2.45%5Y: -1.52%10Y: 1.09%
GSK EPS CAGR:1Y: -78.21%2Y: 0.00%5Y: -18.08%10Y: -6.29%
GSK Net Income CAGR:1Y: -74.21%2Y: 0.00%5Y: -13.89%10Y: -3.72%
GSK EBITDA CAGR:1Y: -15.92%2Y: 55.35%5Y: -0.75%10Y: 5.57%
GSK Free Cash Flow CAGR:1Y: 51.68%2Y: 24.60%5Y: 9.77%10Y: 4.82%
GSK Free Cash Flow / Share CAGR:1Y: 64.48%2Y: 9.92%5Y: -3.01%10Y: -1.75%
GSK Operating Income CAGR:1Y: -81.45%2Y: 59.53%5Y: -24.32%10Y: -10.33%
GSK Gross Profit CAGR:1Y: -2.32%2Y: 4.60%5Y: -0.15%10Y: 2.05%
GSK Shares Outstanding CAGR:1Y: -0.98%2Y: -0.96%5Y: 0.04%10Y: 0.35%
GSK Share Buybacks CAGR:1Y: -2.84%2Y: 0.00%5Y: 7.86%10Y: 38.34%
GSK Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
GSK Expenses CAGR:1Y: -23.21%2Y: -37.50%5Y: -23.84%10Y: -4.00%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
GSK Actual Revenue CAGR:1Y: -1.61%2Y: 2.45%5Y: -1.52%10Y: 1.09%
GSK Actual EPS CAGR:1Y: -78.21%2Y: 0.00%5Y: -18.08%10Y: -6.29%
GSK Actual Net Income CAGR:1Y: -74.21%2Y: 0.00%5Y: -13.89%10Y: -3.72%
GSK Actual EBITDA CAGR:1Y: -15.92%2Y: 55.35%5Y: -0.75%10Y: 5.57%
Ratios, Profit Margins & Return on Capital:
GSK Net Profit Margin CAGR:1Y: -78.05%2Y: 0.00%5Y: -16.67%10Y: -7.02%
GSK Gross Profit Margin CAGR:1Y: 2.00%2Y: 2.86%5Y: 1.94%10Y: 1.21%
GSK Price to Earnings CAGR:1Y: 471.90%2Y: 0.00%5Y: 29.94%10Y: 8.45%
GSK Price To Sales Ratio CAGR:1Y: 27.25%2Y: 10.66%5Y: 8.61%10Y: 0.98%
GSK Return on Capital Employed CAGR:1Y: -7.98%2Y: 114.13%5Y: 11.61%10Y: 5.41%
GSK Return on Invested Capital CAGR:1Y: -4.75%2Y: 109.59%5Y: 7.83%10Y: 0.56%
GSK Dividends Info:
Annual Dividend:
$1.80056
Forward Yield:
3.56%
Ex-Dividend Date:
2026-08-14
Lifetime Dividends / Share:
$62.01
GSK Dividend History: Dates, Payments & Yield list
Below is a schedule of all GSK dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 08/14/2026 | 10/08/2026 | $0.450 | 3.64% | 3.87% | $46.54 |
| 05/15/2026 | 07/09/2026 | $0.455 | 3.66% | 3.47% | $52.47 |
| 02/20/2026 | 04/09/2026 | $0.478 | 3.21% | 3.27% | $58.36 |
| 11/14/2025 | 01/08/2026 | $0.433 | 3.67% | 3.45% | $50.22 |
| 08/15/2025 | 10/09/2025 | $0.430 | 4.37% | 3.96% | $43.44 |
| 05/16/2025 | 07/10/2025 | $0.435 | 4.62% | 4.39% | $39.58 |
| 02/21/2025 | 04/10/2025 | $0.401 | 4.37% | 4.77% | $33.60 |
| 11/15/2024 | 01/09/2025 | $0.389 | 4.67% | 4.62% | $33.69 |
| 08/16/2024 | 10/10/2024 | $0.386 | 3.74% | 3.93% | $39.21 |
| 05/16/2024 | 07/11/2024 | $0.376 | 3.35% | 3.87% | $38.90 |
| 02/22/2024 | 04/11/2024 | $0.406 | 3.85% | 3.98% | $40.80 |
| 11/16/2023 | 01/11/2024 | $0.340 | 3.95% | 3.43% | $39.64 |
| 08/17/2023 | 10/12/2023 | $0.361 | 4.15% | 3.9% | $37.01 |
| 05/18/2023 | 07/13/2023 | $0.348 | 3.95% | 3.99% | $34.80 |
| 02/23/2023 | 04/13/2023 | $0.342 | 3.88% | 3.57% | $38.32 |
| 11/17/2022 | 01/12/2023 | $0.317 | 3.89% | 3.61% | $35.15 |
| 08/18/2022 | 10/06/2022 | $0.391 | 4.57% | 5.21% | $30.00 |
| 05/19/2022 | 07/01/2022 | $0.350 | 3.21% | 3.2% | $43.75 |
| 02/24/2022 | 04/07/2022 | $0.622 | 6.04% | 5.38% | $46.23 |
| 11/18/2021 | 01/13/2022 | $0.523 | 5.04% | 4.65% | $45.06 |
| 08/19/2021 | 10/07/2021 | $0.530 | 5.07% | 5.48% | $38.66 |
| 05/20/2021 | 07/08/2021 | $0.527 | 5.4% | 5.27% | $39.97 |
| 02/18/2021 | 04/08/2021 | $0.628 | 7.24% | 6.89% | $36.46 |
| 11/12/2020 | 01/14/2021 | $0.496 | 5.25% | 5.2% | $38.16 |
| 08/13/2020 | 10/08/2020 | $0.491 | 4.77% | 5.29% | $37.16 |
| 05/14/2020 | 07/09/2020 | $0.472 | 4.62% | 4.68% | $40.37 |
| 02/20/2020 | 04/09/2020 | $0.599 | 5.61% | 6.17% | $38.88 |
| 11/14/2019 | 01/09/2020 | $0.489 | 4.46% | 4.19% | $46.65 |
| 08/08/2019 | 10/10/2019 | $0.464 | 4.58% | 4.39% | $42.25 |
| 05/16/2019 | 07/11/2019 | $0.495 | 5.04% | 4.84% | $40.93 |
| 02/21/2019 | 04/11/2019 | $0.597 | 5.89% | 5.83% | $40.94 |
| 11/15/2018 | 01/10/2019 | $0.491 | 4.86% | 4.99% | $39.36 |
| 08/09/2018 | 10/11/2018 | $0.501 | 4.9% | 5.21% | $38.47 |
| 05/10/2018 | 07/12/2018 | $0.530 | 5.31% | 5.08% | $41.75 |
| 02/22/2018 | 04/12/2018 | $0.638 | 6.98% | 6.28% | $40.62 |
| 11/09/2017 | 01/11/2018 | $0.504 | 5.63% | 5.47% | $36.84 |
| 08/09/2017 | 10/12/2017 | $0.496 | 5.02% | 4.84% | $41.02 |
| 05/10/2017 | 07/13/2017 | $0.488 | 4.62% | 4.59% | $42.50 |
| 02/22/2017 | 04/13/2017 | $0.576 | 5.62% | 5.51% | $41.81 |
| 11/02/2016 | 01/12/2017 | $0.464 | 4.7% | 4.76% | $39.01 |
| 08/10/2016 | 10/13/2016 | $0.499 | 4.52% | 4.71% | $42.39 |
| 05/11/2016 | 07/14/2016 | $0.554 | 5.25% | 5.05% | $43.87 |
| 02/17/2016 | 04/14/2016 | $1.252 | 12.71% | 11.74% | $42.64 |
| 11/10/2015 | 01/14/2016 | $0.582 | 5.68% | 5.78% | $40.28 |
| 08/12/2015 | 10/01/2015 | $0.593 | 5.38% | 6.12% | $38.74 |
| 05/13/2015 | 07/09/2015 | $0.577 | 5.18% | 5.52% | $41.80 |
| 02/18/2015 | 04/09/2015 | $0.695 | 5.88% | 5.83% | $47.72 |
| 11/05/2014 | 01/08/2015 | $0.613 | 5.43% | 5.68% | $43.19 |
| 08/06/2014 | 10/02/2014 | $0.648 | 5.43% | 5.68% | $45.63 |
| 05/14/2014 | 07/10/2014 | $0.640 | 4.64% | 4.71% | $54.40 |
| 02/19/2014 | 04/10/2014 | $0.750 | 5.38% | 5.71% | $52.55 |
| 11/13/2013 | 01/09/2014 | $0.616 | 4.74% | 4.66% | $52.84 |
| 08/07/2013 | 10/03/2013 | $0.553 | 4.29% | 4.35% | $50.84 |
| 05/08/2013 | 07/11/2013 | $0.550 | 4.33% | 4.16% | $52.91 |
| 02/20/2013 | 04/11/2013 | $0.689 | 6.08% | 5.68% | $48.52 |
| 11/14/2012 | 01/03/2013 | $0.579 | 5.53% | 5.27% | $43.98 |
| 08/08/2012 | 10/04/2012 | $0.528 | 4.48% | 4.45% | $47.45 |
| 05/09/2012 | 07/05/2012 | $0.549 | 4.83% | 4.77% | $46.01 |
| 02/15/2012 | 04/12/2012 | $0.821 | 7.38% | 7.22% | $45.47 |
| 11/02/2011 | 01/05/2012 | $0.543 | 5.02% | 4.71% | $46.13 |
| 08/03/2011 | 10/06/2011 | $0.521 | 4.78% | 4.92% | $42.37 |
| 05/04/2011 | 07/07/2011 | $0.526 | 4.87% | 4.79% | $43.91 |
| 02/09/2011 | 04/07/2011 | $0.615 | 6.43% | 6.16% | $39.96 |
| 10/27/2010 | 01/06/2011 | $0.507 | 5.15% | 5.19% | $39.05 |
| 07/28/2010 | 10/07/2010 | $0.457 | 5.16% | 4.44% | $41.19 |
| 05/05/2010 | 07/08/2010 | $0.460 | 5.08% | 5.27% | $34.91 |
| 02/10/2010 | 04/08/2010 | $0.574 | 6.12% | 5.91% | $38.86 |
| 11/04/2009 | 01/07/2010 | $0.490 | 4.86% | 4.73% | $41.48 |
| 07/29/2009 | 10/08/2009 | $0.461 | 4.8% | 4.66% | $39.58 |
| 08/13/1997 | 11/30/-0001 | $0.491 | 2.51% | 2.51% | $39.06 |
| 03/19/1997 | 11/30/-0001 | $0.727 | 4.2% | 4.2% | $34.63 |
| 08/16/1996 | 11/30/-0001 | $0.584 | 4.15% | 4.15% | $28.13 |
| 03/22/1996 | 11/30/-0001 | $0.580 | 4.66% | 4.66% | $24.88 |
| 09/22/1995 | 11/30/-0001 | $0.774 | 6.62% | 6.62% | $23.38 |
| 02/24/1995 | 11/30/-0001 | $0.385 | 3.83% | 3.83% | $20.13 |
| 03/04/1998 | 11/30/-0001 | $0.652 | 2.4% | 2.4% | $54.25 |
| 08/12/1998 | 11/30/-0001 | $0.496 | 1.71% | 1.71% | $58.00 |
| 03/03/1999 | 11/30/-0001 | $0.595 | 1.93% | 1.93% | $61.69 |
| 08/11/1999 | 11/30/-0001 | $0.539 | 2.18% | 2.18% | $49.38 |
| 03/01/2000 | 11/30/-0001 | $0.785 | 3.11% | 3.11% | $50.44 |
| 08/09/2000 | 11/30/-0001 | $0.502 | 1.78% | 1.78% | $56.31 |
| 12/27/2000 | 11/30/-0001 | $0.742 | 2.68% | 2.68% | $55.38 |
| 05/02/2001 | 11/30/-0001 | $0.287 | 1.09% | 1.09% | $52.58 |
| 09/23/1994 | 11/30/-0001 | $0.695 | 7.77% | 7.77% | $17.88 |
| 03/14/1994 | 11/30/-0001 | $0.332 | 3.34% | 3.34% | $19.88 |
| 05/15/1987 | 11/30/-0001 | $0.042 | 1.29% | 1.29% | $13.06 |
| 11/20/1987 | 11/30/-0001 | $0.142 | 6.22% | 6.22% | $9.13 |
| 04/18/1988 | 11/30/-0001 | $0.074 | 3.2% | 3.2% | $9.19 |
| 11/18/1988 | 11/30/-0001 | $0.061 | 2.53% | 2.53% | $9.63 |
| 04/07/1989 | 11/30/-0001 | $0.095 | 1.68% | 1.68% | $11.25 |
| 10/05/1989 | 11/30/-0001 | $0.224 | 3.73% | 3.73% | $12.00 |
| 03/30/1990 | 11/30/-0001 | $0.151 | 2.34% | 2.34% | $12.88 |
| 09/24/1990 | 11/30/-0001 | $0.317 | 4.68% | 4.68% | $13.56 |
| 03/15/1991 | 11/30/-0001 | $0.183 | 1.93% | 1.93% | $18.94 |
| 09/16/1991 | 11/30/-0001 | $0.384 | 3.25% | 3.25% | $23.63 |
| 02/28/1992 | 11/30/-0001 | $0.281 | 2.01% | 2.01% | $28.00 |
| 09/21/1992 | 11/30/-0001 | $0.580 | 4.09% | 4.09% | $28.38 |
| 03/05/1993 | 11/30/-0001 | $0.305 | 3.17% | 3.17% | $19.25 |
| 09/24/1993 | 11/30/-0001 | $0.058 | 0.6% | 0.6% | $19.25 |
| 08/01/2001 | 11/30/-0001 | $0.283 | 0.98% | 0.98% | $57.62 |
| 10/31/2001 | 11/30/-0001 | $0.284 | 1.06% | 1.06% | $53.40 |
| 02/15/2006 | 11/30/-0001 | $0.488 | 3.82% | 3.82% | $51.14 |
| 05/10/2006 | 11/30/-0001 | $0.393 | 2.75% | 2.75% | $57.17 |
| 08/02/2006 | 11/30/-0001 | $0.406 | 3.02% | 3.02% | $53.80 |
| 11/01/2006 | 11/30/-0001 | $0.451 | 3.41% | 3.41% | $52.98 |
| 02/14/2007 | 11/30/-0001 | $0.552 | 3.78% | 3.78% | $58.37 |
| 05/02/2007 | 11/30/-0001 | $0.481 | 3.34% | 3.34% | $57.68 |
| 08/01/2007 | 11/30/-0001 | $0.495 | 3.84% | 3.84% | $51.61 |
| 10/31/2007 | 11/30/-0001 | $0.533 | 4.16% | 4.16% | $51.25 |
| 02/13/2008 | 11/30/-0001 | $0.627 | 5.74% | 5.74% | $43.66 |
| 04/30/2008 | 11/30/-0001 | $0.519 | 4.71% | 4.71% | $44.11 |
| 07/30/2008 | 11/30/-0001 | $0.519 | 4.46% | 4.46% | $46.53 |
| 10/29/2008 | 11/30/-0001 | $0.475 | 5.09% | 5.09% | $37.32 |
| 02/11/2009 | 11/30/-0001 | $0.495 | 5.58% | 5.58% | $35.50 |
| 11/02/2005 | 11/30/-0001 | $0.355 | 2.73% | 2.73% | $51.96 |
| 08/03/2005 | 11/30/-0001 | $0.348 | 2.9% | 2.9% | $48.00 |
| 05/11/2005 | 11/30/-0001 | $0.380 | 3.04% | 3.04% | $50.03 |
| 02/20/2002 | 11/30/-0001 | $0.715 | 2.85% | 2.85% | $50.21 |
| 05/01/2002 | 11/30/-0001 | $0.555 | 4.6% | 4.6% | $48.26 |
| 07/31/2002 | 11/30/-0001 | $0.311 | 3.15% | 3.15% | $39.50 |
| 10/30/2002 | 11/30/-0001 | $0.308 | 3.27% | 3.27% | $37.68 |
| 02/19/2003 | 11/30/-0001 | $0.465 | 5.09% | 5.09% | $36.56 |
| 05/07/2003 | 11/30/-0001 | $0.317 | 3.03% | 3.03% | $41.90 |
| 07/30/2003 | 11/30/-0001 | $0.286 | 2.92% | 2.92% | $39.22 |
| 10/29/2003 | 11/30/-0001 | $0.300 | 2.77% | 2.77% | $43.25 |
| 02/18/2004 | 11/30/-0001 | $0.520 | 4.9% | 4.9% | $42.49 |
| 05/12/2004 | 11/30/-0001 | $0.353 | 3.36% | 3.36% | $42.05 |
| 08/04/2004 | 11/30/-0001 | $0.366 | 3.57% | 3.57% | $40.98 |
| 11/03/2004 | 11/30/-0001 | $0.365 | 3.31% | 3.31% | $44.15 |
| 02/16/2005 | 11/30/-0001 | $0.444 | 3.74% | 3.74% | $47.43 |
| 04/29/2009 | 11/30/-0001 | $0.409 | 5.3% | 5.3% | $30.85 |
Projected Future Returns & Dividends for GSK
Based on past 10-year performance, here are GSK growth metrics:
Share price CAGR of +2.19%
Dividend CAGR of -0.71%
Using GSK CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| GSK (DRIP) | GSK - No DRIP | |
|---|---|---|
| Current Price | $50.51 | $50.51 |
| Start Shares | 197.98 | 197.98 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 270.73 | 197.98 |
| Dividends Payment | $0.42 | $0.42 |
| Annual Dividends | $454 | $332 |
| Yield on cost | 4.54% | 3.32% |
| Share Price | $62.72 | $62.72 |
| Total Dividends | $4,060 | $3,452 |
| Final Value | $16,979 | $15,869 |
Estimated Future Value + Dividends - GSK
NOTE: Above numbers are our estimate based on GSK's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Company Info
GSK plc (GSK) had its IPO on 1980-03-28, and is traded on NYSE stock exchange.
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.
GSK website: https://www.gsk.com
Get Full Access to All Reports with DRIPCalc PRO
Get 3 Months Free with Annual Plan
Get 3 Months Free with Annual Plan
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
40% Lifetime Discount
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
40% Lifetime Discount
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
40% Lifetime Discount
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Combined 55% Lifetime Discount
Loading signals…
DCF Model — GSK
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $50.51
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
